Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura
- 1 September 2003
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (9) , 2041-2042
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patientsBlood, 2003
- Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? YesJournal of Thrombosis and Haemostasis, 2003
- Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor–cleaving protease activityBlood, 2002
- Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving proteaseBest Practice & Research Clinical Haematology, 2001
- Thrombotic thrombocytopenic purpura: outcome in 24 patients with renal impairment treated with plasma exchangeTransfusion, 1992
- Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1991
- THROMBOTIC THROMBOCYTOPENIC PURPURAMedicine, 1966